Reports: Fruth Pharmacy has sold nearly 1,000 boxes of tamper-resistant pseudoephedrine product
NEW YORK — Fruth Pharmacy is seeing a positive response from customers in its efforts to limit the sale of OTC cold and allergy medications that contain pseudoephedrine, according to published reports.
The West Virginia MetroNews Network reported that Fruth had sold nearly 1,000 boxes of Acura Pharmaceuticals’ Nexafed, a nasal decongestant that contains tamper-resistant properties to limit its appeal to makers of methamphetamine, and the product has been popular with customers since its introduction at the stores in August.
At the same time it made the announcement about Nexafed, the 25-store, West Virginia-based chain announced it would phase out Johnson & Johnson’s Sudafed, a popular target for meth makers due to the relative ease by which the pseudoephedrine is extracted. Other products with pseudoephedrine, such as Merck’s Claritin-D and Sanofi’s Allegra-D, have been moved behind the counter and out of customers’ view.
In addition, customers who want to buy those drugs at Fruth must first consult with a pharmacist who can determine whether they’re being bought for legitimate purposes, the news site reported.
CEA forecasts personal health-and-wellness product market will reach $8 billion in sales by 2018
ARLINGTON, Va. — The Consumer Electronics Association on Thursday forecast that the evolution of U.S. healthcare will result in a more than 142% increase over the next five years in personal health-and-wellness product sales and software and service revenues.
As part of a new report, titled "The Connected Health and Wellness Market," CEA quantified the growth in sales of connected health and wellness devices.
“The current sea change in healthcare is resulting in far more consumer-centric products and services,” stated CEA president and CEO Gary Shapiro. “Design innovations, advancing technology and the widespread adoption of mobile devices mean consumer-centric care is now possible in ways we never imagined. Continued innovation promises to increase personalization, reduce costs and provide novel new solutions to our healthcare challenges.”
More than 40 million personal health and wellness products are expected to sell in 2013, a figure that will rise to more than 70 million by 2018. Product sales and software and service revenues will see the largest growth, generating more than $3.3 billion in revenue in 2013 and more than $8 billion by 2018.
The report found 29% of mobile phone users with health problems would try an easy-to-use device to track their condition and progress towards their goals. Additionally, 27% of mobile phone users would like a personalized plan to help guide them through their journey to better health.
“Current healthcare reform is driving demand for innovative products and services that people can manage themselves,” Shapiro said. “Consumer electronics companies are paying close attention to the rise of a young, dynamic market for connected health and wellness devices. As a result, these products allow healthcare providers to engage with their patients more effectively and help consumers better self-manage their own care needs.”
Nipro Diagnostics initiates voluntary recall for a small number of meters
FORT LAUDERDALE, Fla. — Nipro Diagnostics on Thursday announced it is initiating a voluntary recall and replacement of a limited number of TRUEbalance and TRUEtrack Blood Glucose Meters distributed both in the United States and outside the United States.
The company has determined that certain isolated TRUEbalance and TRUEtrack Blood Glucose Meters distributed in the United States have an incorrect factory-set unit of measure that displays the glucose result in mmol/L rather than mg/dL. If a consumer were not to notice the incorrect unit of measure, it is possible that the meter result could be read as a lower than expected blood glucose result.
There are 501 affected TRUEbalance meters and 105 affected TRUEtrack meters that were distributed in the United States from September 2008 to May 2013.